Breaking News Instant updates and real-time market news.

TSLA

Tesla

$310.40

46.11 (17.45%)

08:33
10/02/18
10/02
08:33
10/02/18
08:33

Tesla: Demand for Model S, X 'remains high'

  • 09

    Oct

  • 29

    Oct

  • 13

    Nov

TSLA Tesla
$310.40

46.11 (17.45%)

10/01/18
RBCM
10/01/18
NO CHANGE
RBCM
Sector Perform
Tesla SEC settlement is a positive outcome, says RBC Capital
RBC Capital analyst Joseph Spak kept his Sector Perform rating on Tesla after its CEO Elon Musk settled the SEC charges against him for $40M combined and announced his resignation as the Board chairman. The analyst says it was a positive outcome for the company as it will allow it to continue raising capital and keep Musk as the CEO. Spak adds that the outcome of splitting a CEO and chairman positions is also a sign of management "maturity", with hopes that a "true check" on Musk will emerge to bring more accountability on the company's claims and targets.
10/01/18
ADAM
10/01/18
NO CHANGE
Target $316
ADAM
Hold
Musk's settlement with SEC 'positive' for Tesla, says Canaccord
Canaccord analyst Jed Dorsheimer says he believes Elon Musk's settlement with the Securities and Exchange Commission will be "positive" for Tesla shares, as it should improve governance and allow investors to focus solely on the operations. However, the analyst believes the "distractions" have likely impacted operations and now predicts a miss in Model 3 production, at 48,000 vs. expectations of 50,000-55,000. Dorsheimer, who maintains a Hold rating and $316 price target on Tesla shares, says he would become more constructive as details of who the new chairman and independent directors might be or a significant improvement in the operations and profitability of the company.
10/01/18
SBSH
10/01/18
NO CHANGE
Target $258
SBSH
Sell
Tesla risks linger despite settlement removing worst case, says Citi
Citi analyst Itay Michaeli said he expects Tesla shares to recover some ground following the "surprisingly swift" settlement reached by Elon Musk and Tesla with the SEC. While the settlement adds a "much needed dose of stability," it doesn't mark the end of the substantial legal, regulatory, reputational risks that Musk's "go-private saga" created, Michaeli tells investors. The focus will now shift to Q3, but the analyst worries that the ramifications of last week's events might linger on broader sentiment, he added. Michaeli raised his price target on Tesla shares to $258 from $225 given the reduced risk from the SEC settlement, but he keeps a Sell rating on the stock.
10/01/18
MSCO
10/01/18
NO CHANGE
Target $291
MSCO
Equal Weight
Musk's settlement could reverse Tesla's share price decline, says Morgan Stanley
Morgan Stanley analyst Adam Jonas says he believes Elon Musk's settlement with the Securities and Exchange Commission could "substantially" reverse Friday's share price decline for Tesla. In a research note to investors, Jonas admits that the settlement was "fast," but that it significantly lowers the risk of spillover effects on capital markets, company morale and brand value, and that the resolution avoided the worst case scenario, where a prolonged negative newsflow cycle would potentially impair access to capital and demand. Additionally, Jonas notes that the fines appear to be much smaller than investors expected, and sees a chance for the board to be strengthened and diversified. Jonas maintains an Equal Weight rating and $291 price target on Tesla shares.

TODAY'S FREE FLY STORIES

10:30
10/18/18
10/18
10:30
10/18/18
10:30
General news
EIA Natural Gas Storage Change for the week ending October 12 »

Gas Inventories 81 Bcf…

10:30
10/18/18
10/18
10:30
10/18/18
10:30
General news
EIA Natural Gas Storage Change for the week ending October 12 »

Gas Inventories 81 Bcf…

MU

Micron

$41.57

-0.79 (-1.87%)

10:30
10/18/18
10/18
10:30
10/18/18
10:30
Options
1.7K Micron Nov 47 - Dec 52.5 call spreads trade 68c »

1.7K Micron Nov 47 - Dec…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GOOG

Alphabet

$1,101.22

-14.77 (-1.32%)

, GOOGL

Alphabet Class A

$1,111.60

-15.07 (-1.34%)

10:28
10/18/18
10/18
10:28
10/18/18
10:28
Initiation
On The Fly: Top five analyst initiations »

Catch up on today's…

GOOG

Alphabet

$1,101.22

-14.77 (-1.32%)

GOOGL

Alphabet Class A

$1,111.60

-15.07 (-1.34%)

BJ

BJ's Wholesale

$23.62

-0.35 (-1.46%)

CMCSA

Comcast

$36.38

-0.01 (-0.03%)

TRI

Thomson Reuters

$47.07

0.25 (0.53%)

ATOM

Atomera

$4.55

-0.1 (-2.15%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Oct

  • 22

    Oct

  • 24

    Oct

  • 25

    Oct

  • 25

    Oct

  • 25

    Oct

  • 28

    Oct

  • 01

    Nov

  • 06

    Nov

  • 07

    Nov

  • 03

    Mar

IBM

IBM

$131.93

-2.12 (-1.58%)

, GPS

Gap

$25.89

-1.24 (-4.57%)

10:28
10/18/18
10/18
10:28
10/18/18
10:28
Downgrade
On The Fly: Top five analyst downgrades »

Catch up on today's…

IBM

IBM

$131.93

-2.12 (-1.58%)

GPS

Gap

$25.89

-1.24 (-4.57%)

YUM

Yum! Brands

$90.34

-1.03 (-1.13%)

ENLK

EnLink Midstream Partners

$18.27

-0.08 (-0.44%)

WING

Wingstop

$72.38

-1.55 (-2.10%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Oct

  • 22

    Oct

  • 29

    Oct

  • 07

    Nov

  • 13

    Nov

  • 03

    Mar

NKE

Nike

$76.52

0.02 (0.03%)

, UAL

United Continental

$88.41

-0.09 (-0.10%)

10:28
10/18/18
10/18
10:28
10/18/18
10:28
Upgrade
On The Fly: Top five analyst upgrades »

Catch up on today's…

NKE

Nike

$76.52

0.02 (0.03%)

UAL

United Continental

$88.41

-0.09 (-0.10%)

GNRC

Generac

$57.53

1.23 (2.18%)

PTI

Proteostasis

$7.85

5.96 (315.34%)

SB

Safe Bulkers

$2.69

0.11 (4.26%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Nov

TEVA

Teva

$21.53

0.34 (1.60%)

, MYL

Mylan

$32.58

-0.45 (-1.36%)

10:25
10/18/18
10/18
10:25
10/18/18
10:25
Recommendations
Teva, Mylan, Amneal Pharmaceuticals, Novartis analyst commentary  »

Sandoz results…

TEVA

Teva

$21.53

0.34 (1.60%)

MYL

Mylan

$32.58

-0.45 (-1.36%)

AMRX

Amneal Pharmaceuticals

$18.66

0.17 (0.92%)

NVS

Novartis

$86.38

1.04 (1.22%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Oct

  • 19

    Oct

  • 19

    Oct

  • 01

    Nov

  • 07

    Nov

  • 07

    Nov

  • 13

    Nov

  • 28

    Feb

ETP

Energy Transfer Partners

$21.75

-0.055 (-0.25%)

, ETE

Energy Transfer Equity

$17.00

-0.05 (-0.29%)

10:25
10/18/18
10/18
10:25
10/18/18
10:25
Conference/Events
Energy Transfer Partners to host special shareholder meeting »

Special shareholder…

ETP

Energy Transfer Partners

$21.75

-0.055 (-0.25%)

ETE

Energy Transfer Equity

$17.00

-0.05 (-0.29%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Oct

AAPL

Apple

$218.70

-2.5 (-1.13%)

10:21
10/18/18
10/18
10:21
10/18/18
10:21
Periodicals
EU won't pursue action against Ireland over Apple tax bill, Independent says »

The European Commission…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PHAS

PhaseBio

$0.00

(0.00%)

10:21
10/18/18
10/18
10:21
10/18/18
10:21
Syndicate
PhaseBio opens at $5.00, IPO priced at $5.00 »

Citi, Cowen and Stifel…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Oct

GE

General Electric

$12.21

0.015 (0.12%)

10:20
10/18/18
10/18
10:20
10/18/18
10:20
Options
Earnings hedge in GE »

Earnings hedge in GE. The…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

10:20
10/18/18
10/18
10:20
10/18/18
10:20
General news
U.S. leading index rose 0.5% to 111.8 in September »

U.S. leading index rose…

10:20
10/18/18
10/18
10:20
10/18/18
10:20
General news
Today's U.S. reports »

Today's U.S. reports…

10:20
10/18/18
10/18
10:20
10/18/18
10:20
General news
Treasury Action: yields are loitering near highs »

Treasury Action: yields…

10:20
10/18/18
10/18
10:20
10/18/18
10:20
General news
FX Action: The dollar »

FX Action: The dollar was…

LGND

Ligand

$207.27

4.52 (2.23%)

, NVS

Novartis

$86.49

1.15 (1.35%)

10:18
10/18/18
10/18
10:18
10/18/18
10:18
Recommendations
Ligand, Novartis analyst commentary  »

Ligand current valuation…

LGND

Ligand

$207.27

4.52 (2.23%)

NVS

Novartis

$86.49

1.15 (1.35%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Oct

  • 18

    Oct

  • 19

    Oct

  • 19

    Oct

  • 06

    Nov

  • 07

    Nov

PTE

PolarityTE

$13.78

-0.81 (-5.55%)

10:17
10/18/18
10/18
10:17
10/18/18
10:17
Hot Stocks
Breaking Hot Stocks news story on PolarityTE »

PolarityTE trading…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TMO

Thermo Fisher

$230.34

-4.3 (-1.83%)

10:17
10/18/18
10/18
10:17
10/18/18
10:17
Downgrade
Thermo Fisher rating change  »

Follow-up: Thermo Fisher…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Oct

  • 19

    Oct

  • 24

    Oct

HAL

Halliburton

$38.78

-0.78 (-1.97%)

10:17
10/18/18
10/18
10:17
10/18/18
10:17
Downgrade
Halliburton rating change  »

Follow-up: Halliburton…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

10:17
10/18/18
10/18
10:17
10/18/18
10:17
Technical Analysis
NASDAQ market internals summary »

Volume is above average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SPN

Superior Energy

$9.23

-0.39 (-4.05%)

10:17
10/18/18
10/18
10:17
10/18/18
10:17
Downgrade
Superior Energy rating change  »

Follow-up:Superior Energy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

$NYE

NYSE Market Internals

$0.00

(0.00%)

10:16
10/18/18
10/18
10:16
10/18/18
10:16
Technical Analysis
NYSE market internals summary »

Volume is below average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PTE

PolarityTE

$13.78

-0.81 (-5.55%)

10:16
10/18/18
10/18
10:16
10/18/18
10:16
Hot Stocks
PolarityTE jumps 2% to $14.94 after Citron calls shares 'a zero' »

In a new research report…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ATVI

Activision Blizzard

$71.72

-6.53 (-8.35%)

10:15
10/18/18
10/18
10:15
10/18/18
10:15
Recommendations
Activision Blizzard analyst commentary  »

Activision's CoD…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

10:15
10/18/18
10/18
10:15
10/18/18
10:15
General news
Breaking General news story  »

Week of 10/12 EIA Natural…

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.